{"symbol":"LLY","fiscalQuarter":"Q4-2018","reportDate":"2019-02-06","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q4-2018","postBrief":{"headline":"Eli Lilly Misses on EPS \u2014 Stock Down 0.96%","keyNumbers":[{"metric":"EPS","actual":"$1.33","expected":"N/A","surprise":"-5.31%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged the challenges faced in the quarter.","They emphasized a focus on long-term growth despite recent setbacks."],"summary":"Management expressed concerns about current market conditions. They remain committed to their strategic goals but noted the need for caution."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a slight miss on EPS, which contributed to a 0.96% decline in stock price. The lack of revenue data and guidance may have added to investor uncertainty. Management's cautious tone suggests they are navigating challenges but are focused on long-term objectives.","metaDescription":"Eli Lilly (LLY) Q4 2018 earnings: EPS missed expectations. Stock down 0.96%. Full breakdown."}}